Navigation Links
Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
Date:1/24/2012

BETHESDA, Md., Jan. 24, 2012 /PRNewswire/ -- The National Foundation for Cancer Research announced today that Dr. Zhen-Yi Wang and Dr. Zhu Chen have been awarded the 7th annual Szent-Gyorgyi Prize for Progress in Cancer Research for their innovative research that led to the successful development of a new therapeutic approach to acute promyelocytic leukemia (APL). 

By combining traditional Chinese medicine with Western medicine, Drs. Wang and Chen have provided dramatic improvement in the five-year disease-free survival rate of APL patients - from approximately 25 percent to 95 percent - making this therapy a standard of care for APL treatment throughout the world, and turning one of the most fatal diseases into a highly curable one.

"I am so glad to see that the efforts we have devoted to research on leukemia these last several decades have led to solid clinical benefits to APL patients around the world," said Dr. Wang. "This award will inspire us as we continue our efforts to find more effective therapies to treat cancers." 

"This is a great honor for Dr. Wang and me; it is quite humbling to know that our respected colleagues from many  scientific disciplines have selected us for this prestigious award," said Dr. Chen, who also serves as China's Minister of Health. "Scientists across the globe are working every day to cure cancer. I hope our work may continue to inspire others."

A clinical researcher at the Ruijin Hospital in Shanghai in the early 1980s, Dr. Zhen-Yi Wang performed the first successful therapy on APL patients using all-trans retinoic acid (ATRA), which significantly increased the survival rate of patients with APL. Dr. Zhu Chen, a former student of Wang, made major contributions to the identification of the molecular mechanisms of both ATRA and arsenic trioxide in APL. He also demonstrated in clinical trials that arsenic trioxide, a compound used as a traditional Chinese medicine for over 2,
'/>"/>

SOURCE The National Foundation for Cancer Research
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2. Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
3. Miami Beach Real Estate Attorney Announces Services to Assist Chinese and other International Real Estate Investors Purchase Discount Florida Homes
4. DuPont and Chinese Academy of Agricultural Sciences Collaborate to Advance Crop Insect Control, Increase Yield
5. SAFC Biosciences(R) Expands Media Capability for Chinese Hamster Ovary (CHO) Cell Lines
6. Sinobiopharma Applies For Two Chinese Patents For Cisatracurium Besylate
7. Neogen Partners With Chinese Government
8. MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners
9. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
10. NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
11. SAFC Biosciences(R) Defines Hydrolysate Components That Enhance Chinese Hamster Ovary (CHO) Cell Line Protein Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015  Tikcro Technologies Ltd. (OTCQB: ... to continue trading on OTCQB  Marketplace, the market ... Marketplace allows for a continuous public market for ... have real-time quotes and market information on us ... OTCQB Marketplace includes U.S. and international companies in ...
(Date:5/5/2015)... NEW YORK , May 5, 2015 /PRNewswire/ ... today announced that Andrew Gengos , President and ... on May 7, 2015. DATE:  Thursday, May ... LINK:  http://VirtualInvestorConferences.com > click the ... will be a live, interactive online event where ...
(Date:5/5/2015)... 2015 Research and Markets ( ... "Clinical Laboratory, Molecular Diagnostics and Genomic Testing ... - Global Version" report to their offering. ... area of molecular diagnostics and pharmacogenics hold the ... market that is moving out of the national ...
(Date:5/5/2015)...   Tocagen Inc. , a clinical-stage immuno-oncology ... , M.D., a venture partner at New Enterprise ... of directors of Tocagen. Dr. Parkinson has more ... development, including leading clinical activities at Amgen and ... cancer therapeutics Gleevec®, Femara®, Zometa®, Kepivance® and Vectibix®, ...
Breaking Biology Technology:Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4
... 28 f-star, an antibody,engineering company developing novel antibodies ... today announced that it,has raised EUR 3.0 million from ... financing round, originally co-led by Aescap Venture and Atlas ... Series A round,increases to EUR 9.0 million. In total, ...
... Va., Nov. 28 LifeNet Health,a leading ... with IMS (Integrated Medical Systems International, Inc.), ... for LifeNet,Health customers, improving the tracking of ... the development, marketing, distribution, and,support of a ...
... Fla., Nov. 28 News briefs concerning the,economic and ... Tampa Bay,Partnership:, SRI Launches First Major Project to ... a five-year, $36.5 million contract,to develop a Maritime Domain ... technologies for improving port security in,the United States. The ...
Cached Biology Technology:Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 2Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 3LifeNet Health and IMS Announce Partnership 2Highlights of Economic and Business Growth in the Tampa Bay Region 2Highlights of Economic and Business Growth in the Tampa Bay Region 3Highlights of Economic and Business Growth in the Tampa Bay Region 4
(Date:5/5/2015)... 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, reminds investors and media that ... is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series ... is themed Global Fraud: Where is the Trust in ...
(Date:4/20/2015)... April 20, 2015 Huntington Memorial Hospital is ... implant a new miniaturized, wireless monitoring sensor to manage ... first and only FDA-approved heart failure monitoring device that ... used by physicians to manage heart failure. ... implanted in the pulmonary artery (PA) during a non-surgical ...
(Date:4/13/2015)... NEW YORK , April 13, 2015 /PRNewswire/ ... study by TechSci Research, "Global Biometrics Market Forecast & ... to register a CAGR of around 14% till ... various governments for large scale implementation and review ... technology and launch of new products with greater ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... is pleased to announce the names of the recipients ... rigorous selection process in a global competition. A total ... applicants originating from 61 different countries. HFSP postdoctoral ... of the Ph.D. degree who wish to broaden their ...
... has selected eight of its fellowship holders to receive ... a rigorous selection process in a global competition, these ... grant to jump start their first independent laboratory. ... spread over three years and supports the research in ...
... BOSTON, MAAccording to a new study, the last few meals ... Fat tissue is one of the most dominant components that ... during major surgery. Researchers at Brigham and Women,s ... chemical balance of fat tissuechemicals that are known to communicate ...
Cached Biology News:The 2013 HFSP postdoctoral fellowship awards 2The Human Frontier Science Program selects new heads of start-up laboratories 2What you eat before surgery may affect your recovery 2
... Macro-Prep ion exchange media are rigid macroporous ... high flow rates at moderate pressures, while ... sites, and the hydrophilic matrix reduces nonspecific ... high-capacity strong anion exchanger with very high ...
... a large collection of phage display ... cell lines, and mouse tissues. All ... vector. The size of cDNA inserts ... 200bp to 1000bp by gel electrophoresis ...
... kit is a competitive enzymeimmunoassay (EIA) for ... or rat serum or plasma. Corticosterone is ... rats and mice, and in most non-mammalian ... Most mammals produce both corticosterone and cortisol, ...
Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain EB....
Biology Products: